{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:24:11Z","timestamp":1743740651899},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.prro.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T01:08:39Z","timestamp":1689037719000},"page":"522-530","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Interfraction Setup Uncertainty of Patients With Glioblastoma Wearing TTFields (Tumor Treating Fields) During Radiation Therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Mingyuan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2023.06.006_bib0001","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2023.06.006_bib0003","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.prro.2023.06.006_bib0004","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","article-title":"NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality","volume":"48","author":"Stupp","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2023.06.006_bib0005","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide versus temozolomide alone for glioblastoma: A randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2023.06.006_bib0006","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide versus maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2023.06.006_bib0007","unstructured":"NCCN Guidelines. Central Nervous System Cancer (2023 Version1). [EB\/OL]. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1425. Accessed April 5, 2023."},{"key":"10.1016\/j.prro.2023.06.006_bib0008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13014-017-0941-6","article-title":"Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells","volume":"12","author":"Giladi","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0009","doi-asserted-by":"crossref","first-page":"ii50","DOI":"10.1093\/neuonc\/noab180.172","article-title":"P14.64 PriCoTTF trial: A phase I\/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma","volume":"23","author":"Kebir","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fonc.2020.00411","article-title":"Concurrent tumor treating fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A prospective safety and feasibility study","volume":"10","author":"Bokstein","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0011","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11060-022-04146-w","article-title":"Concurrent chemoradiation and tumor treating fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: Patterns of progression in a single institution pilot study","volume":"160","author":"Ali","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0012","article-title":"Scalp-sparing radiation with concurrent temozolomide and TTFs for patients with newly diagnosed glioblastoma","volume":"12","author":"Ryan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0013","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/cam4.1095","article-title":"Analysis of physical characteristics of tumor treating fields for human glioblastoma","volume":"6","author":"Lok","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.prro.2023.06.006_bib0014","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/cam4.210","article-title":"Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma","volume":"3","author":"Wong","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.prro.2023.06.006_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13014-020-01521-7","article-title":"Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial","volume":"15","author":"Guberina","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0016","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jocn.2017.04.002","article-title":"The effect of Optune\u2122 tumor treating fields transducer arrays on skin radiation dose during radiotherapy","volume":"42","author":"Bender","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.prro.2023.06.006_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fonc.2018.00051","article-title":"Dosimetric impact of a tumor treating fields device for glioblastoma patients undergoing simultaneous radiation therapy","volume":"8","author":"Li","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13014-018-0976-3","article-title":"Dosimetric impact of tumor treating field (TTfield) transducer arrays onto treatment plans for glioblastomas - a planning study","volume":"13","author":"Straube","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0019","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/acm2.13144","article-title":"Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I\/II trial[J]","volume":"22","author":"Nour","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.prro.2023.06.006_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1748-717X-7-133","article-title":"IGRT versus non-IGRT for postoperative head-and-neck IMRT patients: Dosimetric consequences arising from a PTV margin reduction","volume":"7","author":"Schwarz","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/jco.2013.31.18_suppl.1","article-title":"RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM)","volume":"31","author":"Gilbert","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.06.006_bib0022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.semradonc.2003.10.003","article-title":"Errors and margins in radiotherapy","volume":"14","author":"van Herk","year":"2004","journal-title":"Semin Radiat Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850023001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850023001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T19:58:03Z","timestamp":1714593483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850023001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1879850023001789"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2023.06.006","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Interfraction Setup Uncertainty of Patients With Glioblastoma Wearing TTFields (Tumor Treating Fields) During Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}